IntraBio’s Aqneursa Becomes Second Approved NPC Therapy In Four Days

 
• By Joseph Haas
  
Niemann-Pick type C
IntraBio's Aqneursa becomes the second approved therapy for Niemann-Pick disease type C • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip